Quarterly Result14 Oct 2026, 04:18 pm
Bacil Pharma Declares Unaudited Q2 FY27 Results
AI Summary
Bacil Pharma Limited announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results during a meeting held on October 14, 2026. A limited review report from the statutory auditors was also approved. The company will submit the detailed financial results and the limited review report in the prescribed format.
Key Highlights
- Bacil Pharma's Board approved unaudited financial results.
- Results are for the quarter and half-year ended September 30, 2026.
- A limited review report from statutory auditors was also approved.
- Results will be submitted in the prescribed SEBI format.
Price Impact
More from BACPHAR